The combined approach of OGM and NGS is changing the way researchers approach workflows for evaluation of hematologic malignancies. In this presentation, Dr. Ravindra Kolhe, from Augusta University, shares a unique approach to heme evaluation, combining OGM with a 523-gene panel on NGS. He reviews the results of this combination and shares one of the first visualizations of the combination of OGM and sequencing data using NxClinical software, which enables a streamlined interpretation for both data types in an integrated simplified view for faster time to results.